Tri Locum Partners LP Catalent, Inc. Transaction History

Tri Locum Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $778,820 - $1.13 Million	-24,202 Reduced 8.46%	261,797 $11.8 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $3.76 Million - $4.27 Million	85,002 Added 42.29%	285,999 $13 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $777,447 - $1.64 Million	-24,402 Reduced 10.83%	200,997 $8.72 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $10.2 Million - $16.7 Million	225,399 New	225,399 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $9.2 Million - $14.4 Million	127,079 Added 117.4%	235,320 $17 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $9.44 Million - $12.3 Million	108,241 New	108,241 $11.6 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $2.23 Million - $2.95 Million	-23,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $2.83 Million - $3.3 Million	23,700 New	23,700 $3.03 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.